Advanced Targeting Systems, Inc. Announces $3 Million Award

SAN DIEGO, Sept. 23, 2010 — Advanced Targeting Systems, the
company that pioneered the targeting of specific cell types
 to manipulate them for the treatment of diseases and for
 research into the function of biological systems, has been
 awarded $3 million from the National Cancer Institute (NCI).
Representatives from the NCI stated that the proposal was
 ranked #1 for funding out of a nationwide program with
 hundreds of applicants. Advanced Targeting Systems will use

 the funds to advance its patented drug, SP-SAP, over the
 next two years to initiate clinical trials for cancer pain.

Related posts:

1. New Baylor President wants $100 million for scholarships
2. USDA Announces Conservation Reserve Program General Sign-up
3. PIT BULL SPAY/NEUTER PROGRAM HELPS LOCAL PET OWNERS

More Photos of Advanced Targeting Systems, Inc. Announces $3 Million Award